Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) |
| BNF code | 0501060E0BBAAAA |
| Virtual Medicinal Product | Clindamycin 300mg/2ml solution for injection ampoules |
| Name | Dalacin C Phosphate 300mg/2ml solution for injection ampoules |
| Abbreviated name | Dalacin C Phosphate 300mg/2ml inj ampoules |
| Date of name applicability | 21 Jan 2009 |
| Previous name | Dalacin C Phosphate 300mg/2ml solution for infusion ampoules |
| Supplier | Pfizer Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intravenous |
| Licensed Route | |
| Licenced route | Intramuscular |
| Actual Medicinal Product Packs | |
| Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) 5 ampoule | |
dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20250505000001, imported on 5th May 2025 at 04:58:39.